Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leila G Lackey

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Environmental Monitoring and Assessment|December 3, 2013
Selecting the optimum plot size for a California design-based stream and wetland mapping programLeila G Lackey, Eric D Stein
Circulation|August 23, 2021
Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMISLeila G Lackey, Christine E Garnett, Fred Senatore
Environmental Health Perspectives|July 20, 2007
The persistence of fluoroquinolone-resistant Campylobacter in poultry productionLance B Price, Leila G Lackey, Rocio Vailes, et al.
International Journal of Food Microbiology|February 8, 2011
Prevalence of potentially neuropathic Campylobacter jejuni strains on commercial broiler chicken productsChristopher G Hardy, Leila G Lackey, Jessica Cannon, et al.
Environmental Health Perspectives|December 19, 2007
Elevated risk of carrying gentamicin-resistant Escherichia coli among U.S. poultry workersLance B Price, Jay P Graham, Leila G Lackey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 10, 2023
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque PsoriasisLeila G Lackey, Xinyi Ng, Jorien Veldwijk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2023
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceTommi Tervonen, Jorien Veldwijk, Katherine Payne, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Environmental Monitoring and Assessment|December 3, 2013
Selecting the optimum plot size for a California design-based stream and wetland mapping programLeila G Lackey, Eric D Stein
Circulation|August 23, 2021
Applying Decision Analysis to Inform the US Food and Drug Administration's Benefit-Risk Assessment of Ticagrelor for Primary Prevention of Myocardial Infarction or Stroke Based on THEMISLeila G Lackey, Christine E Garnett, Fred Senatore
Environmental Health Perspectives|July 20, 2007
The persistence of fluoroquinolone-resistant Campylobacter in poultry productionLance B Price, Leila G Lackey, Rocio Vailes, et al.
International Journal of Food Microbiology|February 8, 2011
Prevalence of potentially neuropathic Campylobacter jejuni strains on commercial broiler chicken productsChristopher G Hardy, Leila G Lackey, Jessica Cannon, et al.
Environmental Health Perspectives|December 19, 2007
Elevated risk of carrying gentamicin-resistant Escherichia coli among U.S. poultry workersLance B Price, Jay P Graham, Leila G Lackey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 10, 2023
Illustrating Emerging Good Practices for Quantitative Benefit-Risk Assessment: A Hypothetical Case Study of Systemic Biologic Treatments for Plaque PsoriasisLeila G Lackey, Xinyi Ng, Jorien Veldwijk, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|April 2, 2023
Quantitative Benefit-Risk Assessment in Medical Product Decision Making: A Good Practices Report of an ISPOR Task ForceTommi Tervonen, Jorien Veldwijk, Katherine Payne, et al.
Pageof 1